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Shwachman-Diamond syndrome (SDS) is an autosomal recessive disorder characterized by exocrine pancreatic
insufficiency and hematologic and skeletal abnormalities. A genomewide scan of families with SDS was terminated
at ∼50% completion, with the identification of chromosome 7 markers that showed linkage with the disease. Finer
mapping revealed significant linkage across a broad interval that included the centromere. The maximum two-
point LOD score was 8.7, with D7S473, at a recombination fraction of 0. The maximum multipoint LOD score
was 10, in the interval between D7S499 and D7S482 (5.4 cM on the female map and 0 cM on the male map), a
region delimited by recombinant events detected in affected children. Evidence from all 15 of the multiplex families
analyzed provided support for the linkage, consistent with a single locus for SDS. However, the presence of several
different mutations is suggested by the heterogeneity of disease-associated haplotypes in the candidate region.
Shwachman-Diamond syndrome (SDS [MIM 260400]),
also known as “Shwachman syndrome,” “Shwachman-
Bodian syndrome,” or “congenital lipomatosis of the
pancreas,” is a rare disorder first reported in 1964 (Bod-
ian et al. 1964; Shwachman et al. 1964). Multiple organs
are affected, and there is a broad range in severity of
presentation even among affected siblings (Burke et al.
1967; Shmerling et al. 1969; Aggett et al. 1980; Savilah-
ti and Rapola 1984), although impaired exocrine pan-
creatic function and hematologic abnormalities with
depressed myeloid cell lineages are the most consistent
features (Ginzberg et al. 1999). Exocrine pancreatic in-
sufficiency typically manifests in infancy, although some
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improvement may be seen with age (Hill et al. 1982;
Mack et al. 1996). In addition to persistent or inter-
mittent neutropenia and an increased susceptibility to
infections, hematologic problems also can include ane-
mia, thrombocytopenia, and pancytopenia (Smith et al.
1996). SDS is considered to be a genetic bone mar-
row–failure syndrome; patients with SDS are at in-
creased risk of development of myelodysplasia and he-
matologic malignancy—in particular, acute myeloge-
nous leukemia (Huijgens et al. 1977; Woods et al. 1981;
Smith et al. 1996). Skeletal abnormalities include de-
layed maturation, metaphyseal chondrodysplasia of the
long bones, and thoracic-cage abnormalities with cos-
tochondral thickening (Aggett et al. 1980; Dhar and An-
derton 1994; Mack et al. 1996). Short stature occurs in
50% of patients (Ginzberg et al. 1999). Other common
anomalies include hepatomegaly and abnormal liver-bi-
ochemical tests, both found in younger patients (Aggett
et al. 1980; Ginzberg et al. 1999). Behavioral and learn-
ing difficulties have also been reported in some patients
(Aggett et al. 1980; Kent et al. 1990).
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Figure 1 Pedigrees of families with SDS, indicating individuals
from whom DNA was available. The families were from Canada, the
United States, England, and The Netherlands; all families were white,
and none were known to have consanguineous matings. Affected in-
dividuals are denoted by black symbols. A, Multiplex families used to
map the SDS locus to chromosome region 7p12-q11. B, Additional
families used in the refined mapping (see table 1).
An unusual combination of organs are affected in
SDS, and, to date, the basic pathophysiological defect is
unknown. Segregation analysis of an international col-
lection of families supports an autosomal recessive mode
of inheritance (Ginzberg et al. 2000). Molecular analysis
(Ikegawa et al. 1999) and family studies (Goobie et al.
1999) have excluded those regions of chromosomes 6
and 12 that were pinpointed in a study of the one patient
known to have a constitutional chromosomal abnor-
mality in the form of the balanced de novo translocation
t(6;12)(q16.2:q21.2) (Masuno et al. 1995). In the pres-
ent study, linkage analysis was used to establish the chro-
mosomal location for SDS.
Most of the families with SDS included in the present
study have been described elsewhere, and additional
families have been obtained through ongoing recruit-
ment (Ginzberg et al. 1999; Goobie et al. 1999). Di-
agnosis was rigorously determined for all patients; the
criterion for inclusion was the presence of both exocrine
pancreatic dysfunction and hematologic abnormalities,
including neutropenia and other bone marrow fail-
ure–associated problems. Consent was obtained from all
participating families, and procedural approval was ob-
tained from the human subjects review board of The
Hospital for Sick Children, Toronto (HSC). Genomic
DNA was extracted either from Epstein-Barr virus–
transformed lymphoblastoid cell lines or directly from
peripheral white-blood-cell pellets, as described by Mil-
ler et al. (1988).
A panel of simple sequence length polymorphic mark-
ers from the Cooperative Human Linkage Center Hu-
man Screening Set, version 6.0 (Dubovsky et al. 1995),
supplemented with selected Ge´ne´thon markers (Dib et
al. 1996), was used to initiate a genomewide scan of 13
multiplex and 8 simplex families. The markers had an
average heterozygosity of .75 and an average intermark-
er distance of 12 cM. In brief, PCRs were set up, with
DNA from each family member, with fluorescently la-
beled oligonucleotides (Research Genetics). Amplified
products of an average of eight markers were pooled
into groups based on expected allele sizes and labels.
Products were analyzed, after separation by electropho-
resis on an ABI 377 sequencer (PE Biosystems), as de-
scribed by Rioux et al. (1998).
Linkage was analyzed under the assumption that SDS
is a completely penetrant autosomal recessive trait. We
estimated the disease-allele frequency to be .0036, based
on an incidence of 1/76,563. The incidence of SDS was
obtained by multiplying the cystic fibrosis (CF) incidence
(1/2,500) by the ratio of the number of patients with
SDS ( ) to the number of patients with CFNp 24
( ), cared for at HSC during a recent 21-yearNp 735
period. We assumed that levels of ascertainment were the
same for both diseases. Marker-allele frequencies were
estimated from the genotypes of the founders in the ped-
igrees, by PEDMANAGER, version 0.9 (M. J. Daly, per-
sonal communication). Linkage analysis was performed
by the FASTLINK, version 4.1P, of the LINKAGE pro-
grams (Lathrop et al. 1984; Cottingham et al. 1993;
Scha¨ffer et al. 1994). Two-point LOD scores were com-
puted by MLINK, under the assumption that there is no
sex difference in recombination rates. After 228 markers
were genotyped, the genomewide scan was terminated
because one locus, D7S1830, had a two-point LOD score
of 4.2 at a recombination fraction (v) of .05. Two prox-
imal loci, D7S817 and D7S1808, also gave positive LOD
scores, of 0.9 and 1.8, respectively, at .vp .1
To map the putative SDS locus more precisely, 27 ad-
ditional chromosome 7 markers, spanning 40 cM (sex-
averaged map), were genotyped in families with either
two or three affected children (fig. 1 and table 1). Markers
were selected from public resources, with a preference for
those included in recently assembled genetic maps (Bro-
man et al. 1998). PCRs were set up to use either a[35S]-
dATP (Goobie et al. 1999) or g[33P]-dATP (Amersham
Pharmacia Biotech) end-labeled oligonucleotides (Hudson
et al. 1997), after optimization for MgCl2 levels (1–1.5
mM) and annealing temperatures. Alleles were assigned
Table 1
Two-Point Linkage between the SDS Locus and Chromosome 7 Loci
LOCUS
DISTANCE ON GENETIC MAPa
(cM)
MAXIMUM LOD SCORE





D7S1808 41.69 43.59 39.84 1.49 (.200/.061)
D7S817 50.29 54.42 46.27 2.20 (.104/.055)
D7S2206 … … … 1.64 (.238/.060)
D7S691 63.67 70.54 56.97 2.58 (.224/0)
D7S679 69.03 81.29 56.97 3.46 (.193/0)
D7S665 69.56 81.29 58.04 3.34 (.240/0)
D7S2506 69.56 81.29 58.04 5.00 (.068/0)
D7S1818 69.56 81.29 58.04 3.77 (.071/0)
D7S2422 72.78 87.74 58.04 3.95 (.100/0)
D7S1830d 72.78 87.74 58.04 4.61 (.170/0)
D7S506 73.84 89.88 58.04 7.16 (0/0)
D7S2552 74.38 90.94 58.04 3.95 (.052/0) 2442
EGFRd … … … 5.32 (.053/0)
D7S2550d 75.44 93.08 58.04 5.91 (.041/0) 2458
D7S793d … … … 4.20 (.068/0)
D7S499d 75.98 94.15 58.04 6.26 (.085/0) 2495
D7S659d 75.98 94.15 58.04 7.19 (0/0)
D7S473d 76.71 95.62 58.04 8.74 (0/0)
D7S494d 76.71 95.62 58.04 8.57 (0/0)
D7S2429d 76.71 95.62 58.04 7.11 (0/0) 2741
D7S2512d 77.91 98.03 58.04 7.16 (0/0)
D7S2549d 77.91 98.03 58.04 5.92 (0/0) 2836
D7S663d 78.65 99.50 58.04 7.71 (0/0)
D7S502d 78.65 99.50 58.04 7.13 (0/0) 2907
D7S482d 78.65 99.50 58.04 3.56 (.103/0)
D7S1839d 78.65 99.50 58.04 7.08 (.072/0)
D7S2503 78.65 99.50 58.04 4.61 (.058/0)
D7S2483 78.65 99.50 58.04 5.01 (.068/0) 2960
D7S1816 83.99 105.92 62.34 4.13 (.165/0)
D7S2204 90.95 116.64 65.53 3.64 (.366/0)
a From the Center for Medical Genetics Web site, in Kosambi centimorgans (Broman et al. 1998);D7S473
and D7S494 were ordered by recombination in one family, and D7S2512 and D7S2549 were ordered by
YAC/BAC mapping. The occurrence of satellite-repeat sequences (D7Z2) localizes the centromere near
D7S2429, as indicated in The Genetic Location Database Web site (Collins et al. 1996). D7S793-D7S499
and D7S482-D7S1839-D7S2503, which flank the block of eight nonrecombinant loci, were ordered ac-
cording to the composite location in The Genetic Location Database. No recombination was observed
between the SDS locus and D7S506; D7S506 was not informative in one of the two potentially informative
families and was not typed in the other. The sex-averaged genetic map was used for the multipoint analysis
by GENEHUNTER 2.0; increments of 0.1 cM were added for subsequent loci assigned to the same position.
A locus not included on the Center for Medical Genetics map was ordered according to The Genetic Location
Database and was positioned, by linear interpolation, between the closest flanking loci on the Center for
Medical Genetics map.
b p maximum-likelihood estimate of the female recombination fraction; p maximum-likelihoodˆ ˆv vf m
estimate of the male recombination fraction.
c From the G3 radiation-hybrid map (version 2.0) of the Stanford Human Genome Center Web site,
selected for LINKMAP multipoint analysis. The markers were assigned to different bins in the same block,
in a physical order consistent with genetic mapping. D7S2483 was placed 0.1 cM distal to D7S502 on the
female map. Although the average map distance per centiray (cR) along chromosome 7 is 20 kb, the accurate
sizes of the bins at the centromere are unknown (Stewart et al. 1997). Both long-range mapping (Wevrick
and Willard 1991) and our effort to establish a physical map support a large physical size of the centromeric
region of chromosome 7.
d Fifteen families were included in the linkage analysis (12 families were included for the remaining loci;
see fig. 1).
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Figure 2 Multipoint LOD scores for the location of the SDS locus. Black circles (●) indicate the positions of the markers. The map of
30 markers appears to be longer than is indicated in table 1 because the Haldane mapping function was used. Black triangles () indicate the
positions of the two markers flanking the candidate region, and white triangles () indicate the positions of the markers used in the genomewide
scan. LOD scores !2.5 are not shown.
after electrophoreses of PCR products on 6% polyacryl-
amide gels and autoradiography (Goobie et al. 1999).
Maximum-likelihood estimates of sex-specific v values
were computed by ILINK. A maximum LOD score of 8.7
was obtained with D7S473, at (table 1). LODvp 0
scores 13 were obtained over a large region (35 cM on
the female map and 8.6 cM on the male map) that includes
the centromere. We have no evidence of SDS locus het-
erogeneity; in each of the 15 families, the expected LOD
scores (Leal and Ott 1990) at were obtained forvp 0
at least one marker in the candidate chromosome 7 cen-
tromeric region.
Multipoint linkage analysis, by GENEHUNTER, ver-
sion 2.0 (Kruglyak et al. 1996; Kruglyak and Lander
1998), using the marker order and sex-averaged map in
table 1, indicated a maximum LOD score of 10 in the
most likely interval, between D7S499 and D7S482 (fig.
2). The next-most-likely interval, which includesD7S506,
had a multipoint LOD score of 5.3. It is noteworthy that
male recombination is markedly suppressed (table 1) in
the centromeric region, over a female genetic distance of
∼20 cM, with a peak ratio of distance in females to dis-
tance in males (female:male distance ratio) of ∼8 at the
centromere (Broman et al. 1998). Thus, we selected seven
markers (table 1) encompassing the candidate region, for
multipoint analysis by the LINKMAP program in the
FASTLINK package, which allows for sex differences in
recombination rates. The maximum multipoint LOD
score with a sliding window of five markers was 10, and
there were only small (!0.7) differences between the scores
that resulted when a female:male distance ratio of 8 or 1
was used.
Haplotypes, from GENEHUNTER 2.0, for the eight
markers in the region of no recombination were ex-
amined. None of the affected children in the 15 families
were homozygous for the eight-marker haplotype. The
SDS-associated haplotypes are diverse; of the 30 hap-
lotypes, only 2 were identical. This shared haplotype was
found in two families from the United States but was
not found among the normal chromosomes; that is, it
was not found among parental chromosomes not trans-
mitted to affected children.
The discovery of a locus for SDS indicates that posi-
tional cloning will be a feasible approach for identification
of the basic defect. A single SDS gene that resides within
the critical interval is anticipated, although the diversity
of SDS-associated haplotypes is compatible with the ex-
istence of a number of different mutations. The generation
of a detailed physical map of the SDS critical interval,
which would provide a working framework, is compli-
cated by the presence of the centromere and associated
satellite-repeat sequences. Characterization of pericen-
tromeric regions of chromosomes has revealed other types
of repetitive sequences, as well as recent intra-/interchro-
mosomal sequence duplications, that result in active or
inactive remnants of genes, such as pseudogenes or partial
genes (Eichler et al. 1996; Ritchie et al. 1998; Eichler
1999; Jackson et al. 1999). Also notable is the limited
availability of annotated genomic sequences for these
regions, which further hampers the rapid characterization
of candidate genes. Nevertheless, 150 gene/expressed-se-
quence–tag clusters or transcription units that map across
the interval delimited by D7S499 and D7S482 (5.4 cM
in the female map and 0 cM on the male map) have been
identified. Of the known genes—includingGBAS,GUSB,
CCT6A, and FKBP9, among others—that have been con-
firmed, by complementary methods, to map to the SDS
gene region, none have biological function or defined ex-
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pression patterns that suggest that they are obvious can-
didates for the SDS gene. Many of the remaining cDNA
clusters are presently insufficiently characterized for direct
assessment, but some have recognizable transcription-fac-
tor motifs and warrant prioritization in more-detailed
investigations.
On chromosome 7, there are local variations in female
and male genetic distances, with the most pronounced
difference being at the centromere (Broman et al. 1998).
In the families included in the present study, we did not
observe male recombination with any of the 21 markers
assigned to the same position on the male map (table
1), consistent with an absence of male recombination in
the families used to build the genetic map (Broman et
al. 1998).
From the perspective of bone marrow failure and he-
matopoietic-cell chromosomal abnormalities, the map-
ping of the SDS locus to the centromeric region of chro-
mosome 7 is provocative. Both myelodysplastic syndrome
(MDS) and acute myelogenous leukemia (AML) are se-
rious complications of SDS, with indications of risk as
high as 30%–35% (Smith et al. 1996). Monosomy 7 and
deletion of 7q are acquired changes frequently seen in the
bone marrow cells of patients with either MDS or AML
(Luna-Fineman et al. 1995; Mitelman et al. 1997); iso-
chromosome 7 formation has also been reported (Mer-
tins et al. 1994). Although chromosomal changes gen-
erally predict a poor prognosis, both their role in the
development of cancer, and patients’ susceptibility to their
formation, are unknown. Formation of isochromosome
7q has been reported in five patients with SDS; one of
these patients has neither MDS nor AML (Dror et al.
1998; Maserati et al. 2000). It is tempting to speculate
that mutations in the SDS gene may increase susceptibil-
ity to somatic chromosomal changes. However, the way
in which this may occur is not readily predictable. Ac-
quired chromosome 7–associated changes of the bone
marrow cells are not unique to SDS, nor are there any
direct indications that SDS carriers are at increased risk
for hematologic problems. Furthermore, some observed
alterations to chromosome 7, such as non–whole arm
translocations, do not appear to involve the centromere
directly. A finding that does hint at events associated with
the centromere is the report of chromosome 7 centromeric
heteromorphism in bone marrow cells from a patient with
SDS who showed no evidence of either MDS or AML
(Sokolic et al. 1999). The heteromorphism occurred in an
otherwise intact chromosome and was sustained for 16
mo. Although there is one other report of chromosome
7 heteromorphism, involving the bone marrow cells of a
25-year-old woman (without SDS) in remission from pre-
B lymphoblastic leukemia (Duval et al. 2000), the true
occurrence of centromeric heteromorphism in bone mar-
row cells is unknown, since whole-chromosome and cen-
tromeric analyses are not necessarily performed simul-
taneously. Heteromorphism may be due to deletions of
centromeric repeat sequences, as a result of misalignment
and unequal crossing over, but it has not been found for
chromosome 7, either in cells of peripheral blood or in
established lymphoblastoid lines (Lo et al. 1999). More
information is needed to understand whether the SDS
locus plays any role in the development of abnormal chro-
mosomes or changes in chromosome numbers.
The identification of a locus for SDS provides the start-
ing point for the identification, by positional cloning, of
a gene with SDS-causing mutations and for the applica-
tion of genetic diagnosis in families at risk. Studies di-
rected toward an understanding of the function of the
gene should help explain the variability of disease symp-
toms and should provide insight into the development of
bone marrow failure and of the preleukemic and leukemic
states.
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